HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.

Moini, Maryam; Fung, Scott

Moini, Maryam; Fung, Scott.

Affiliation

Moini M; Department of Medicine, University of Ottawa, Ottawa, ON K1Y 4E9, Canada.
Fung S; Department of Medicine, University of Toronto, Toronto, ON M5G 2C4, Canada.

Viruses ; 14(4)2022 03 22.

Article in En | MEDLINE | ID: mdl-35458387

Subject(s)

Hepatitis B, Chronic; Nucleic Acids; Antiviral Agents; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B virus/genetics; Hepatitis B, Chronic/drug therapy; Humans

Key words

HBV cure; antiviral therapy; hepatitis B surface antigen (HBsAg); hepatitis B virus (HBV)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nucleic Acids / Hepatitis B, Chronic Limits: Humans Language: En Journal: Viruses Year: 2022 Document type: Article Affiliation country: Canada Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google